arsenic has been researched along with alitretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X | 1 |
| Aoki, A; Hiromori, Y; Ido, A; Kimura, T; Nagase, H; Nakanishi, T | 1 |
2 other study(ies) available for arsenic and alitretinoin
| Article | Year |
|---|---|
[Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; Drug Resistance, Neoplasm; Drug Synergism; HL-60 Cells; Humans; Oxides; Tretinoin | 2000 |
Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARĪ³ Nuclear Receptors.
Topics: Alitretinoin; Arsenicals; Cell Line, Tumor; DNA; Genes, Reporter; Humans; Ligands; Luciferases, Renilla; Organometallic Compounds; Organophosphorus Compounds; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Terphenyl Compounds; Thiazolidinediones; Transcription, Genetic; Tretinoin | 2016 |